What a Private Equity Investment Committee Reads First

A Committee Reads the Exit Before It Reads the Business

An investment committee has a narrower problem than most readers of a transaction document. It is not assessing whether a business is good, whether the sector is attractive, or whether the deal team has worked hard. It is deciding whether to commit capital that must be returned, with a return, within a period, through a sale to somebody who does not yet exist as a named party. Everything in the memo is read in the service of that question, and the question runs backwards: what does this get sold for, to whom, on what basis, and what has to happen between now and then.

That orientation explains most of what deal teams find counter-intuitive about how memos are received. A committee will spend little time on a beautifully constructed market section and a great deal on two lines of the exit assumption. It will accept a business it does not find especially interesting and decline one it likes, because interest is not the criterion. And it will focus relentlessly on the difference between what the management team projects and what the deal team believes, because that difference is where the committee's judgement is actually being exercised.

The other structural feature worth naming early is that the committee is reading the deal team as well as the deal. The people presenting have spent months on the transaction, have usually formed a view, and are — entirely honestly — subject to the commitment that comes from months of work. Committees know this and correct for it. A memo that shows the team correcting for it themselves, by presenting the case against with the same rigour as the case for, is treated differently from one that requires the committee to supply the scepticism. This is the same dynamic that governs a board paper, and it produces the same conclusion: advocacy is discounted, and analysis is not.

This article sets out how an IC memo is actually read: the order the reading takes, the first three questions that arrive almost immediately, where diligence findings have to appear if they are to be assessed rather than discovered, how an exit thesis is pressure-tested and why the buyer universe matters more than the multiple, the distinction between a management case and an IC case and how a committee reads the deviation between them, and why the framing "what would have to be true" is the one that decides. Where our transaction advisory practice supports a buy-side process, the analysis is built to answer these questions before the memo is drafted rather than in response to it.

The Memo Is Read in an Order It Was Almost Certainly Not Written In

Deal teams write memos in the order the work was done: origination and process, company and market, management, financial performance, diligence findings, the plan, the model, valuation, exit, and a recommendation at the end. Committees read the summary, then the price and structure, then the exit assumption, then the deviation between the management case and the deal team's case, and only then the material that supports any of it. By the time a committee member reaches the market section they have already formed a provisional view and are reading to test it.

The practical consequence is that the first page is not an introduction; it is the memo. A summary that recites what the company does and how the opportunity arose has spent the most valuable space in the document on the least contested material. A summary that states the price, the structure, the entry basis, the return the case produces, the exit assumption it depends on, and the two or three things that would have to be true for that to happen has given the committee the frame it will use for everything else — and a committee working from the deal team's frame is in a very different conversation from one that has constructed its own.

The valuation and exit sections deserve to be positioned accordingly. Where they sit near the end, they are reached by readers who have already decided what to worry about, and they are then read for confirmation of an existing concern rather than on their own terms. Where they sit early, they are read as the argument they are. This is not a presentational trick: the exit assumption is the load-bearing element of the entire case, and burying it behind forty pages of context communicates something about how central the team considers it to be.

The section that is read most sceptically, wherever it sits, is the value creation plan. Committees have read many of them, and the recurring weakness is a plan composed of initiatives that are individually plausible and collectively unaccountable — margin improvement, pricing optimisation, commercial excellence, operational efficiency — each with a number attached and none with a named owner, a start date, a cost, or a mechanism by which the committee would know six months later whether it had happened. A plan with three initiatives that can be tracked is worth more to a committee than a plan with nine that cannot, and the arithmetic difference between them in the model is generally the point at which the case stops being credible.

Three Questions Arrive Almost Immediately, and They Are Always the Same Three

Whatever the sector and whatever the structure, the opening exchange in an investment committee tends to reduce to three questions. They are not always asked in words, and an experienced team answers them in the memo before they are put — which is the difference between presenting a case and defending one.

The first is why this is available. A business being sold is being sold by somebody who knows it better than the buyer does, and the reason for the sale is information. A fund exiting at the end of its hold period, a founder retiring, a corporate divesting a unit that no longer fits, a family resolving a succession — each is a benign and complete explanation. What concerns a committee is the absence of an explanation, or one that does not survive contact with the facts: a vendor selling at what appears to be the bottom of a cycle, an asset that has been marketed before and withdrawn, a process running unusually fast. None of those is disqualifying and each requires an answer, because the committee will otherwise supply its own.

The second is what we are paying for that the seller has not already been paid for. An entry price capitalises the business as it is, including whatever the current owner has already built. The return has to come from something else: operational improvement the current owner did not make, growth the current owner could not fund, a multiple re-rating the business has not yet earned, or deleveraging. Committees test whether the answer is genuine, because a case in which the return comes mostly from paying a low multiple and selling at a higher one, with no argument for why the higher one is deserved, is a case that depends on the market rather than on the fund.

The third is what has to go right. Not what could go wrong — a risk register answers that and answers it weakly — but which specific things must occur for the case to deliver, and how many of them there are. A case that requires three things to happen, each within the fund's influence, is a different proposition from one that requires seven, of which four depend on third parties. Committees count. A memo that has counted first, and states the number plainly, has done the most useful work in the document.

Where our transaction advisory practice supports a buy-side process, those three questions are answered in the analysis before the memo is drafted, because each of them can change the transaction rather than merely the presentation of it. A weak answer to the second question in particular frequently indicates that the price is wrong rather than that the memo needs improving, and that is considerably better to establish before a committee establishes it.

A Diligence Finding Has to Land Somewhere, and "Noted" Is Not a Landing

Diligence produces findings. The question a committee asks is not what was found but what was done about it — and the possible answers are few: the price moved, the structure changed, a protection was obtained, the plan was adjusted, or the finding was assessed and accepted. Each of those is a legitimate landing. What is not legitimate, and is immediately visible, is a finding that appears in a summary and then has no consequence anywhere else in the memo. A finding without a landing has been reported rather than addressed, and a committee reading a list of such findings concludes that the diligence informed the memo without informing the deal.

The summary formulation that attracts the most scepticism is the one asserting that no material issues were identified. Something material is found in essentially every process, because businesses are not uniform and diligence is designed to surface variation. A statement that nothing was found is generally read as indicating either that the work did not reach far enough or that the team has calibrated materiality to the outcome it wanted. The stronger position, even where the findings were genuinely modest, is to state what was found, what it was worth, and why it did not change the price — which is an assessment, and an assessment can be evaluated.

The earnings work deserves particular emphasis because it sits directly beneath the entry price. Where a quality-of-earnings review has moved the sustainable earnings figure, the committee needs to see the movement and needs to see the entry multiple restated on the tested figure rather than the presented one. A multiple quoted on the vendor's adjusted EBITDA, with the diligence findings described separately in another section, has presented two facts that must be combined by the reader — and the reader will combine them, arriving at a higher effective multiple than the memo stated. The companion article on quality of earnings sets out how that number is examined; what matters here is that the tested figure, not the presented one, must be the number the price is expressed against throughout.

Working capital and net debt findings land differently but require the same discipline. Where diligence has established that the working capital requirement is higher than presented, or that items in the bridge should be treated as debt-like, those findings affect the equity cheque and therefore the return — and they belong in the price discussion in the memo rather than in a schedule. The companion article on the enterprise-to-equity bridge sets out that mechanism in full; the point for a committee memo is that a finding affecting cash to seller is a finding affecting the fund's entry, and it must appear where the entry is discussed.

The most useful presentation of diligence findings is therefore a short table rather than a narrative: what was found, what it is worth in value terms, and where in the transaction it was dealt with. That format makes the landings visible and makes an unlanded finding conspicuous — which is exactly why it is worth adopting. Where our financial due diligence team supports a buy-side process, findings are reported against that structure from the first week, so the memo can be assembled from work already framed as consequences rather than as observations.

The Exit Multiple Is Not an Assumption; It Is a Claim About Who Buys and Why

Most of the return in most private equity cases is realised at exit, which makes the exit assumption the single most load-bearing element in the memo — and it is routinely the least supported. An exit multiple stated as a number, benchmarked against a range of transactions in the sector, has asserted that the market will be there. A committee wants the argument beneath it: which classes of buyer would acquire this business at that point, what each would be buying it for, and on what basis each would value it.

That reframing changes the analysis substantially, because different buyers value on different bases and want different things. A strategic acquirer is buying a position, a capability or a customer base, can fund synergies, and may pay a multiple that no financial buyer would justify — but only if the business is genuinely strategic to somebody identifiable, and only if the business is of a scale that matters to them. A financial buyer is underwriting their own return from the position the fund leaves behind, which means their price depends on what growth and improvement remains after the current plan has been executed. A public market exit depends on scale, on a track record of predictable delivery, and on conditions nobody can forecast. Each of these is a different claim and each is testable now.

The test that most often exposes a weak exit thesis is asking what the next owner buys. Where the value creation plan extracts the available improvement — the margin has been fixed, the pricing has been optimised, the acquisitions have been integrated — the business handed to a financial successor has less left in it, and a successor underwriting their own return may not pay the multiple that was assumed. A case that requires the fund to capture all the improvement and simultaneously requires the next buyer to pay for improvement is internally inconsistent, and it is a common inconsistency. The resolution is usually that the plan should leave something identifiable for the next owner, and saying so explicitly is a mark of a case that has been thought through.

Multiple expansion deserves to be treated as the exceptional claim it is. Assuming exit above entry is assuming the business will be worth more per unit of earnings than it is today, and that requires a reason: greater scale, better earnings quality, reduced customer concentration, a shift from project revenue to recurring revenue, a move from founder dependence to institutional management. Where such a reason exists it should be stated as the specific claim it is, and the memo should say how the committee would know at exit whether it had been achieved. Where no reason exists, the honest assumption is exit at entry or below, and a case that works on that basis is materially stronger than one that requires the market to be kind.

Timing carries more of the return than deal teams typically present. An exit later than assumed compounds against the return even where every operational assumption is delivered in full, and processes slip for reasons that have nothing to do with performance — a soft window, a change in the buyer universe, a delayed audit, an unresolved dispute. Where our valuation team tests an exit thesis, the analysis identifies the classes of buyer and their basis of valuation before any multiple is selected, and the sensitivity is run on timing as well as on multiple, because the two together describe the actual range of outcomes far better than either alone.

The Committee Reads the Gap Between the Two Cases, Not Either Case Alone

A memo commonly carries two projections: the management case, prepared by the people running the business, and the case the deal team is actually underwriting. Committees read both, and what they read most carefully is the difference — line by line, with the reason for each divergence. That difference is the clearest available evidence of what the deal team learned and how much of it they were willing to act on.

The pathological outcome is a deal team case that matches management's. It occurs more often than it should, and it admits of only two explanations, neither of which helps: either the diligence found nothing that changed the view, which is implausible in most processes, or the team found things and did not reflect them because reflecting them would have made the transaction harder to justify at the agreed price. A committee cannot distinguish these from the document, and will treat the identity of the two cases as the finding.

Equally telling is a deviation applied as a uniform haircut — management's case with every growth rate reduced by a fixed proportion. That is not analysis; it is a gesture toward conservatism that reveals no view about which specific assumptions are wrong. It also produces a case that is internally incoherent, since the reasons an assumption is optimistic differ line by line: a pipeline may be overstated because it double-counts opportunities, a margin may be overstated because a cost was omitted, a growth rate may be overstated because it assumes a competitor does not respond. A case that reflects those reasons specifically is defensible; a uniform reduction is not.

The most useful presentation is a reconciliation: management's revenue, then each adjustment with its reason and the evidence supporting it, arriving at the underwritten figure — and the same for margin and for capital expenditure. Presented that way, a committee can assess each judgement separately, agree with some and disagree with others, and form a view about the whole without having to reconstruct the analysis. It also makes the deal team's reasoning available for the years afterwards, which matters at the point where the investment is being reviewed against what was underwritten.

There is a further distinction worth drawing, because collapsing it causes real confusion in committee. The case being underwritten is not the same as the case being incentivised. Management will be incentivised against a plan, and that plan is frequently more ambitious than the case the fund is underwriting — deliberately, and reasonably. Where the memo does not separate them, the committee cannot tell which number the fund is relying on. Where our transaction advisory practice supports a buy-side process, the underwritten case and the management plan are presented as separate documents with the reconciliation between them shown, because a committee that is unclear which case it is approving will approve neither. That practice is consistent across a network of 80+ specialist consultants working in 22 countries, where committee conventions differ but this particular confusion does not.

"What Would Have to Be True" Is the Question That Actually Decides

The most useful framing available to anyone preparing an IC memo inverts the usual one. Instead of asking whether the case is right — which invites advocacy on one side and scepticism on the other, and resolves nothing — ask what would have to be true for it to be right, list those things, and then assess each on its own. The question is not rhetorical. It produces a short list of propositions, each of which can be evidenced, tested or acknowledged as unknowable, and it converts a debate about a conclusion into an examination of its components.

Its power is that it neutralises the dynamic that otherwise dominates the room. A committee confronted with an advocated case adopts the opposing position by default, and the discussion becomes a contest in which the deal team defends and the committee attacks — a process that surfaces objections in an order determined by who thinks of what, and which frequently ends without either side knowing whether the important questions were reached. A committee handed a list of five propositions the case depends on has a structured agenda: it can accept three, question one and reject one, and the resulting decision is about the case rather than about the presentation.

The exercise is genuinely uncomfortable to perform honestly, which is why it is valuable. It requires the deal team to identify the propositions they are least sure of, and to say so, at the moment they are asking for approval. But a team that names its own weakest link is treated very differently from one whose weakest link is found: the first has demonstrated judgement, and the second has demonstrated that its judgement needs supervision. Committees are considerably more willing to approve a case with an acknowledged uncertainty than one with a discovered weakness of the same magnitude.

It also produces better transactions rather than merely better memos, which is the more important claim. Where a proposition on the list cannot be evidenced, there is usually something to be done about it before approval is sought — an additional piece of diligence, a contractual protection, an adjustment to structure, a condition to completion, a change to the plan. The list functions as a work programme, and the discipline of producing it early frequently changes the deal. In the mandates our advisers run on the buy side, the propositions are drafted before the memo is written for exactly that reason: it is the version of the exercise that can still change the outcome.

The final property is that the list survives the transaction. A memo built this way leaves behind an explicit record of what the fund believed and why, which is the document that matters at the first annual review, at the point where the plan diverges, and at exit when someone asks whether the case was delivered. That is the same function a board paper serves in a governance review, and it is the same reason the honest version outperforms the persuasive one: the persuasive document is read once, and the honest one is read for years.

The Memo Is an Instrument for Deciding, Not a Case for Approving

This series has described five institutional readers, and the same conclusion has arrived at each of them from a different direction. A credit committee reads backwards from repayment and needs the minimum rather than the average. A public authority reads for what the file can carry into a permanent record. A development institution reads for what changes because it participated. A board reads for whether it can demonstrate it knew what it was deciding. An investment committee reads for what would have to be true. In every case the document that succeeds is the one that answers the reader's actual question rather than the one its author found most natural to argue — and in every case the honest version outperforms the persuasive one, not for reasons of principle but because these readers have all seen the persuasive version many times.

For an IC memo specifically the practical discipline is short. State the proposition on the first page: price, structure, the tested earnings figure the multiple is struck on, the exit assumed and who buys. Land every diligence finding somewhere visible — price, structure, protection, plan, or an explicit acceptance. Argue the exit as a claim about identifiable buyers and their basis of valuation rather than as a benchmarked number, and say what remains for the next owner. Show the reconciliation between the management case and the case being underwritten, line by line with reasons, and label which is which. And put the list of things that would have to be true on the page, including the one the team is least sure of.

None of that requires an adviser and none of it is proprietary; it is a description of how these documents are read, drawn from work delivered by a network of 80+ specialist consultants across 22 countries and offered because the reading is consistent enough to be described. Where our transaction advisory practice supports a buy-side process, this is the structure the analysis is built to, and the reason is entirely practical: a memo built this way is faster to approve, survives the years in which the investment is reviewed against what was underwritten, and occasionally prevents a transaction that should not have happened. A deal team that applies it without instructing anybody has been served correctly, which is the only outcome any article in this series is aiming at.